Clinical Trial Update: Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial on perioperative gabapentin for pain management in head and neck cancer surgery; study terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: University of California, Davis | Conditions: Cancer of Head and Neck, Narcotic Use | Phase 3 | Status: TERMINATED | Results posted: 2021-07-09